Latest News
7/29/11
Thermo Fisher, Agere announce collaboration to offer GMP Hot Melt Extrusion
Thermo Fisher and Agere have announced today they will make available their combined expertise and capabilities to benefit companies working on formulation using twin-screw melt extrusion for melt granulation and solid dispersions of poorly soluble compounds. The offering will accelerate formulation development and strive to reduce time and cost to FIH proof of concept studies. Thermo Fisher will install its state-of-the-art Pharma 16 Hot Melt Extruder at Agere's GMP facility located in Bend, OR. Agere will utilize its in-depth knowledge of solid dispersions and HME to develop improved formulations. Agere will evaluate the formulations using its novel testing methodologies to rank order formulations with respect to anticipated bioavailability. This offering will allow customers a single site to have process/formulation development, scale-up and GMP manufacturing. Read Press Release
7/15/11
Agere expands cGMP capabilities through acquisition of Anhydro MS 150 Spray Drier
Agere acquires an Anhydro MS 150 spray drier for installation in the state-of-the-art cGMP facility, offering cGMP manufacturing of clinical trial material. Agere's expertise in spray dried dispersions affords a scalable process from the development stage to the manufacturing stage on the Anhydro MS 150.
7/15/11
Agere to attend American Association of Pharmaceutical Scientists conference
Agere will be attending the 25th annual American Association of Pharmaceutical Scientists (AAPS) meeting and exposition on October 23 – 27, 2011 in Washington, DC. Please stop by to discuss how Agere's rapidly expanding portfolio of manufacturing, formulation and analytical capabilities can be utilized to accelerate your path to market.
6/15/11
Mr. Ryan Minikis joins Agere team as QC Director
Agere is pleased to announce that Mr. Ryan Minikis has joined the Agere team as Quality Control Director. Mr. Minikis will be responsible for analytical method development and validation efforts as well as comprehensive QC laboratory operations including cleaning verification, raw material and finished product testing, and ICH stability programs. Mr. Minikis has over 10 years of experience in roles ranging from formulation development to GLP and GMP laboratory operations. Mr. Minikis has extensive knowledge of solid dispersion development and technical transfer to the cGMP manufacturing environment.
6/15/11
Agere to attend Controlled Release Society conference
Agere will be attending the 38th annual meeting and exposition of the Controlled Release Society (CRS) on July 30 – August 3, 2011 in National Harbor, MD. Stop by booth 702 to learn more about our Agere's current and future cGMP capabilities.
10/22/10
Agere Expands into New Facility
Agere has moved into a new state-of-the-art 10,000 sq. ft. facility in order to provide cGMP manufacturing of formulations and to expand analytical services. The new facility will eventually provided spray drying, solid dosage form, and parenteral development and manufacturing.
10/20/10
Mr. Doug Hecker joins Agere as Global Director of Business Development
Agere is pleased to announe that Mr. Doug Hecker has joined the Agere team as Global Director of Business Development. Mr. Hecker will be responsible for all business development and sales of Agere's novel solubilization, analytical, and formulation technologies. Mr Hecker has over 20 years experience in both business development and as a pharmaceutical scientist, along with an extensive quality assurance background. Mr. Hecker has extensive knowledge of solid dispersion manufacturing and development under cGMP conditions.
10/10/10
Mr. Vince Foley joins Agere as Quality Director
Agere is pleased to announce that Mr. Vince Foley has joined the Agere team as "Quality Director." Mr. Foley will be responsible for implementing and maintaining Agere's quality systems, both for analytical and manufacturing. Mr. Foley has over 20-yrs. experience in the pharmaceutical industry in various quality positions, including direct experience in manufacturing of solid dispersion formulations using spray drying and extensive parenteral formulation.
07/19/10
Agere presented at the “37th Annual Meeting and Exposition
of the Controlled Release Society”
Agere presented “Technologies for Delivering Poorly Soluble
Compounds” as part of the Young Scientist Workshop I: Improving
the Solubility of Poorly Soluble Drugs, the annual CRS meeting in Portaland, OR
Agere also presented “Novel Solid Dispersion Platform for Delivery
of Low Solubility Compounds” at 12:10PM as part of the Innovation
Sunday Soapbox Session,
Agere will exhibited its technology at BOOTH #623
06/10/10
Agere presents “Amorphous solid dispersions” at the
“52nd Annual International Industrial Pharmaceutical Research and
Development Conference (June LOL),” June 7th-11th, 2010,
Devil’s Head Resort and Conference Center, Merrimac, WI
Dr. Dan Smithey Co-founder and CSO of Agere Pharmaceuticals, Inc,
presented an overview of amorphous solid dispersions at the 52nd Annual
International Industrial Pharmaceutical Research and Development Conference
(June LOL). The theme of this year’s conference was “Science
Driven Approaches To Drug Development” The conference was held on
June 7th-11th, 2010 at the Devil’s Head Resort and Conference Center
in Merrimac, WI. Request a copy of Dr. Smithey’s presentation here
5/23/10
Agere launches ORALead™ drug discovery lead selection technology
Agere announces the release of its ORALead™ technology for selection
of optimum insoluble lead compounds. Access to this technology is based on
a fee-for-service business model. More information may be found
here.
11/23/09
Agere Pharmaceuticals receives the 2009 “Outstanding Entrepreneur
of the Year” Award
Agere announces that it has received the 2009 “Outstanding
Entrepreneur of the Year,” award from the Economic Development for
Central Oregon. Agere is excited to be recognized as a leader in the
Biotechnology community in Oregon.
